Cameron Powell, M.D.

Revolutionizing healthcare as pioneers in non-invasive neurostimulation solutions. At Spark Biomedical, we are defined by our boldness, agility, and collaborative spirit. Committed to unlocking the potential of neurostimulation technology for diverse health challenges. We aim to equip providers and researchers with innovative, evidence-based solutions that redefine approaches to treatment -- inspired by our commitment to offer more to patients. Our journey began in Dallas in 2018, where we broke barriers with the Sparrow Therapy System, the first generation of our safe, comfortable, drug-free, and FDA-cleared approach to treating opioid withdrawal symptoms. Today, our second-generation device, Sparrow Ascent is spreading its wings and expanding its impact as we explore more ways to bend the curve on opioid addiction. We are Spark Biomedical – a center for groundbreaking neurostimulation technology, cutting-edge scientific research, and compassionate patient support. We are Spark Biomedical and we’re here to change the world.

Vooks combines the power of video with the educational value of books for a whole new storytime experience! We bring children’s stories to life with subtle animation and deliberately paced narration that mimics a parent or teacher reading aloud. Highlighted text helps kids connect what a word sounds like with what it looks like, and original music and sound engages without overstimulating. Trusted by parents, loved by teachers, and enjoyed by millions of children around the world, the love of reading starts here! Learn more at www.vooks.com

GreenLink Partners is focused on enhancing the sustainability and profitability of American agriculture. We partner with agricultural producers and farmers, offering services and solutions that leverage underutilized land for grid-scale wind and solar projects, convert organic waste into renewable natural gas, and optimize carbon credit generation through various environmental strategies. Our mission is to support farmers to adopt green solutions efficiently, ensuring these practices are both economically profitable and environmentally sustainable.

Revolutionizing healthcare as pioneers in non-invasive neurostimulation solutions. At Spark Biomedical, we are defined by our boldness, agility, and collaborative spirit. Committed to unlocking the potential of neurostimulation technology for diverse health challenges. We aim to equip providers and researchers with innovative, evidence-based solutions that redefine approaches to treatment -- inspired by our commitment to offer more to patients. Our journey began in Dallas in 2018, where we broke barriers with the Sparrow Therapy System, the first generation of our safe, comfortable, drug-free, and FDA-cleared approach to treating opioid withdrawal symptoms. Today, our second-generation device, Sparrow Ascent is spreading its wings and expanding its impact as we explore more ways to bend the curve on opioid addiction. We are Spark Biomedical – a center for groundbreaking neurostimulation technology, cutting-edge scientific research, and compassionate patient support. We are Spark Biomedical and we’re here to change the world.

Modern living breaks down your immune barrier. ARMRA™ Colostrum is the first smart superfood that builds it back. We’re rebuilding health from the inside out. At ARMRA, we use never-been-done, Cold-Chain BioPotent™ technology, and leverage immune intelligence to protect, restore, and enhance complete immune health and cellular performance. Harnessing the power of colostrum and its 200+ bioactive nutrients, we bring together technology and superfood science, empowering you to face the modern world head on. Were ARMRA. The revival of health.

WAVE commercializes world-changing technology to do good in the world. In doing good, we expect our customers, employees, investors, university partners and communities to also do well in the process. The firm is led by seasoned and successful entrepreneurs and operators that have deployed over $600M of capital across 32 companies which have returned over $270M to investors with an additional $1.25B in value yet to distribute. WAVE is now preparing for additional company investments across health, life sciences, aerospace engineering, and energy sectors.